Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units (NURSIE)

February 13, 2019 updated by: French Society for Intensive Care

Nursing Research on the Occurrence of Serious Adverse Events in Intensive Care Unit During Bed Bath and Nursing Care. NURSIE Study

Patients who are hospitalized in intensive care unit (ICU) require basic nursing care to improve patient hygiene, to promote comfort, to prevent pressure ulcer, and foot or hand's retractations.

Those nursing cares require mobilization very frequently which expose critically ill patients to occurrence of serious adverse events (SAE) such as i) hemodynamic, neurologic, and respiratory variations ii) unplanned dislodgement (lines, drains, catheters, endotracheal tube..)

Few study have evaluated relation between SAE occurence and several patient's, service's, health-care provider's caracteristics. We plan to analyse those factors to find some ways to prevent SAE occurence during nursing and hygiene cares.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

262

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bruxelles, Belgium
        • Hopital de Bruxelles
      • Charleroi, Belgium
        • CHU Charleroi
      • Charleroi, Belgium
        • Hôpital Civil Marie Curie
      • Besançon, France
        • CHU Besançon
      • Boulogne-Billancourt, France
        • CHU Ambroise Pare
      • Corbeil-Essonnes, France
        • Ch Sud Francilien
      • Dax, France
        • CH de Dax
      • Draguignan, France
        • CH de la Dracénie
      • Lille, France
        • CHRU Lille
      • Lille, France
        • Hôpital Jeanne de Flandre
      • Marseille, France
        • CHU Marseille
      • Nantes, France
        • CHU Nantes
      • Nice, France
        • CHU Nice
      • Nîmes, France
        • CHU Nîmes
      • Orléans, France
        • CHR Orléans
      • Paris, France
        • Chu Lariboisiere
      • Paris, France
        • Chu La Pitie Salpetriere
      • Paris, France
        • Hôpital Européen George Pompidou
      • Paris, France
        • CHU Necker Enfant Malade
      • Strasbourg, France
        • CHU Strasbourg
      • Toulouse, France
        • CHU Toulouse
      • Valence, France
        • CH Valence
      • Villeneuve-Saint-Georges, France
        • CHI Lucie & Raymond Aubrac
    • A
      • Versailles, A, France
        • CH Andre Migniot
      • Luxembourg, Luxembourg
        • Centre Hospitalier Emile Mayrisch
      • Meyrin, Switzerland
        • Hôpital de la Tour

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Each participating unit will include all consecutive patients staying in the ICU.

Each day a screening of the patients will be released between 8 and 10 am.

Description

Inclusion Criteria:

  • Health-care affiliated
  • Length of ICU stay < 72 h
  • Patient with endotracheal tube
  • Patient with tracheostomy
  • Patient receiving vasoactives drugs (norepinephrine, epinephrine, Dobutamine)
  • Patient undergoing no invasive ventilation during 1hour minimum of 24 hours before the selection
  • Patient undergoing hight flow oxygen therapy heated and humidified

Exclusion Criteria:

  • Patient already included in this study
  • Medical contraindication to the bed bath with lateral mobilization
  • Withdrawal of life sustaining treatment
  • Spinal trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cohort for nursing care
Patients in ICU under oxygen and/or mechanical ventilation and/or vasoactive drugs and/or non-invasive ventilation
The nursing care will be defined as a lateral mobibization and a length of care superior or equal to 10 min

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of occurrence of at least one serious avderse event (SAE) (defined below) during the nursing care while the study period (72 hours)
Time Frame: 72 hours

Determinate incidence of occurrence of at least one SAE (defined below) during the nursing care while the study period (72 hours) The nursing care will be defined as a lateral mobibization and a length of care sup or equal to 10min

SAE are considered according to litterature as :

  • Cardiac arest
  • Unplanned extubation
  • Episode of Spo2 riequiring therapeutic intervention
  • Artificial airway obstruction requiring endotracheal suctionning
  • Unplanned dislodgements related to lines or catheters drains
  • Hypotension with therapeutic intervention
  • Cardiac rhythm disorders with therapeutic intervention
  • Agitation with therapeutic intervention
  • Equipment failure or dysfunction
  • Patient fall
  • Need for doctor help
  • Increased intracranial pressure > 20 mmHg
  • Acute painful crisis
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mathieu Lloung, French Intensive Care Society
  • Study Chair: Jean Baptiste Lascarrou, MD, French Intensive Care Society

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2018

Primary Completion (Actual)

July 15, 2018

Study Completion (Actual)

February 13, 2019

Study Registration Dates

First Submitted

March 11, 2018

First Submitted That Met QC Criteria

March 16, 2018

First Posted (Actual)

March 23, 2018

Study Record Updates

Last Update Posted (Actual)

February 15, 2019

Last Update Submitted That Met QC Criteria

February 13, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2018-A00046-49

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Care

Clinical Trials on Nursing care

Subscribe